To evaluate the efficacy and safety of Zhangyanming tablets combined with Western medicine in the treatment of primary open angle glaucoma(POAG).
A total of 106 patients with POAG in the ophthalmology outpatient department of our hospital from September 2022 to June 2024 were collected and randomly divided into the control group and the observation group, with 53 cases in each group. The control group was given basic western medical treatment, while the observation group was treated with Zhangyanming tablets in combination with the control group. Both groups were treated continuously for 12 weeks. The best corrected visual acuity(BCVA), intraocular pressure, mean defect degree of visual field, visual field index and average thickness of the retinal nerve fiber layer(RNFL) around the optic disc were compared between the two groups. As well as the linear density and perfusion density of the macula, optic disc and peripapillary vessels, the traditional Chinese medicine(TCM) syndrome score and the total effective rate of treatment were statistically analyzed.
A total of 100 patients completed the study, with 50 cases in each of the two groups. After treatment, there were no significant differences in BCVA, intraocular pressure, mean deviation of visual field, and perfusion density of macular, optic disc and peridisc vessels between the two groups(P>0.05). The TCM syndrome score in the observation group were significantly lower than those in the control group(P<0.05), while the visual field index, the average thickness of RNFL, and the linear density of macular, optic disc and peridisc blood vessels in the observation group were significantly higher than those in the control group(P<0.05). The total effective rate of the observation group was higher than that of the control group(82.0% vs. 52.0%, P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).
The combination of Zhangyanming tablets and western medicine can significantly improve visual field defects in patients with POAG, increase the average thickness of the RNFL, improve vascular microcirculation in the macula, optic disc and peridisc vessels, effectively alleviate ocular symptoms, and has good safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |